Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies (Q36909270)

17 August 2017

1 reference

title

Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies (English)

1 reference

post-traumatic stress disorder

17 August 2017

main subject

0 references

pharmacotherapy

0 references

author name string

Wei Zhang

series ordinal

1

1 reference

17 August 2017

Jonathan Rt Davidson

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

1861-1870

1 reference

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Anxiety disorders associated with suicidal ideation and suicide attempts in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Characterizing the effects of sertraline in post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Paroxetine in the treatment of post-traumatic stress disorder: pooled analysis of placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Newer aspects of the reversible inhibitor of MAO-A and serotonin reuptake, brofaromine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Antidepressant-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Tiagabine for posttraumatic stress disorder: effects of open-label and double-blind discontinuation treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

A functional magnetic resonance imaging study of amygdala and medial prefrontal cortex responses to overtly presented fearful faces in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Animal models of relevance to PTSD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Quetiapine treatment in patients with posttraumatic stress disorder: an open trial of adjunctive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

The use of prazosin for the treatment of trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Olanzapine in the treatment of post-traumatic stress disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Inositol treatment of post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Low-dose cortisol for symptoms of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Pilot study of secondary prevention of posttraumatic stress disorder with propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Stress doses of hydrocortisone, traumatic memories, and symptoms of posttraumatic stress disorder in patients after cardiac surgery: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

The effect of stress doses of hydrocortisone during septic shock on posttraumatic stress disorder in survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Maintenance therapy with fluoxetine in posttraumatic stress disorder: a placebo-controlled discontinuation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Tolerability and adherence issues in antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Prescribing patterns for patients with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Post-traumatic stress disorder: a review of psychobiology and pharmacotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Meeting everyday challenges: antipsychotic therapy in the real world

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1861

10.1517/14656566.8.12.1861

21 January 2018

Identifiers

DOI

1 reference

release_iisbfniabbhofgmaoitlru3qdi

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iisbfniabbhofgmaoitlru3qdi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference